Inventor · disambiguated record
Charles L. Bisgaier
Also filed as: BISGAIER CHARLES · BISGAIER CHARLES L · BISGAIER CHARLES LARRY
18 granted patents·23 pending applications·744 citations·filing 1994–2022
95Inventor score
Files withGEMPHIRE THERAPEUTICS INC9WARNER LAMBERT CO7NEUROBO PHARMACEUTICALS INC3PFIZER3BISGAIER CHARLES L2
Top patents by PatentIndex Score
41 records- 0197US5756544ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted May 26, 1998·131 cites·6 claims
- 0296US6680203B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·146 cites·32 claims
- 0394US5648387ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1995·Granted Jul 15, 1997·133 cites·21 claims
- 0493US9849104B2Treatment of NASH with gemcabeneGEMPHIRE THERAPUETICS INC·Filed 2017·Granted Dec 26, 2017·21 cites·15 claims
- 0592US5783600ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted Jul 21, 1998·92 cites·8 claims
- 0690US5750569ACarboxyalkylethers, formulations, and treatment of vascular diseasesWARNER LAMBERT CO·Filed 1997·Granted May 12, 1998·73 cites·8 claims
- 0789US7435717B2Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromesPFIZER·Filed 2004·Granted Oct 14, 2008·38 cites·55 claims
- 0885US10028926B2Methods of reducing risk of cardiovascular diseaseGEMPHIRE THERAPEUTICS INC·Filed 2013·Granted Jul 24, 2018·8 cites·27 claims
- 0985US8557835B2Statin-carboxyalkylether combinationsBISGAIER CHARLES LARRY·Filed 2007·Granted Oct 15, 2013·3 cites·11 claims
- 1080US6362236B1Inhibition of lipoprotein oxidationWARNER LAMBERT CO·Filed 1998·Granted Mar 26, 2002·54 cites·7 claims
- 1175US8119590B2Prevention and treatment of restenosis by local administration of drugBISGAIER CHARLES L·Filed 2002·Granted Feb 21, 2012·13 cites·35 claims
- 1273US12503422B2Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2022·Granted Dec 23, 2025·0 cites·8 claims
- 1371US6974702B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2003·Granted Dec 13, 2005·9 cites·36 claims
- 1468US2014012042A1Calcium Dicarboxylate EthersWARNER LAMBERT CO·Filed 2013·Application pending·0 cites
- 1562US10449154B2Treatment of NASH with GemcabeneGEMPHIRE THERAPEUTICS INC·Filed 2017·Granted Oct 22, 2019·0 cites·20 claims
- 1662US2005148654A1Statin-carboxyalkylether combinationsFiled 2005·Application pending·0 cites
- 1761US5705388ACETP RibozymesRIBOZYME PHARM INC·Filed 1994·Granted Jan 6, 1998·15 cites·14 claims
- 1860US2003105154A1Statin-carboxyalkylether combinationsFiled 2002·Application pending·0 cites
- 1960US2006069163A1Method for treating Alzheimer's diseasePFIZER·Filed 2005·Application pending·0 cites
- 2058US2018325825A1Gemcabene combinations for the treatment of cardiovascular diseaseGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2156US10709678B2Methods of reducing risk of cardiovascular diseaseNEUROBO PHARMACEUTICALS INC·Filed 2018·Granted Jul 14, 2020·0 cites·23 claims
- 2255US2017172955A1Treatment of Mixed DyslipidemiaGEMPHIRE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2354US2008293633A1Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary SyndromesPFIZER·Filed 2007·Application pending·0 cites
- 2454US2008213351A1Compositions and methods for dosing liposomes of certain sizes to treat or prevent diseaseESPERION LUV DEV INC·Filed 2008·Application pending·0 cites
- 2553US2002055529A1Method for treating alzheimer's diseaseFiled 2001·Application pending·0 cites
- 2652US2004092574A1Statin-Lp(a) inhibitor combinationsFiled 2003·Application pending·0 cites
- 2750US2020148617A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforGEMPHIRE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2849US2004038891A1Methods and compositions for the treatment of ischemic reperfusionFiled 2003·Application pending·0 cites
- 2948US2018297929A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3048US2020253877A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3148US2002188012A1Method for treating Alzheimer's diseaseFiled 2002·Application pending·0 cites
- 3248US2004009216A1Compositions and methods for dosing liposomes of certain sizes to treat or prevent diseaseFiled 2003·Application pending·0 cites
- 3347US2018250251A1Treatment of Patients with Familial Hypercholesterolemia on Lipid-Lowering TherapyGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3447US2002103252A1Statin-carboxyalkylether combinationsFiled 2001·Application pending·0 cites
- 3545US8846761B2Method for treating pancreatitisBISGAIER CHARLES L·Filed 2011·Granted Sep 30, 2014·0 cites·16 claims
- 3644US2017246133A1Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapyGEMPHIRE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3743US6231847B1Method of treating vascular proliferative responsesBISGAIER CHARLES LARRY·Filed 1999·Granted May 15, 2001·8 cites·10 claims
- 3841US2007207191A1Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseasesKANZER STEVE H·Filed 2007·Application pending·0 cites
- 3939US2001028895A1Methods of treating alzheimer's diseaseFiled 2001·Application pending·0 cites
- 4038US2019008779A1Gemcabene compositions and methods of use thereofGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4134US2001018427A1Method of using a scavenger receptor in the treatment of atherosclerosisWARNER LAMBERT CO·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles L. Bisgaier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →